Protection of clinical trial participants in countries outside the EU
Document type: report
Download file(s):
342109 (98 KB)
Abstract:
Medicines intended for the European market are increasingly tested on clinical trial participants outside the EU in low and middle income countries. Over the past years, SOMO and Wemos have collected extensive evidence of violations of ethical principles and guidelines in such trials. In this briefing paper SOMO and Wemos provide the European Parliament, the European Commission and the European Medicines Agency(EMA) with policy recommendations to take their responsibility and address this problem.
Series Title:
Briefing Paper
Corporate author(s):
SOMO
,
Wemos
Category:
Policy
Keywords:
health
,
research
,
science and technology
,
poverty
,
law
Language:
eng
Organization:
SOMO - Centre for Research on Multinational Corporations
,
Wemos Foundation
PAGE:
2
Place:
Amsterdam
Publisher:
SOMO [etc.]
Year:
2011
Right:
© 2011 SOMO & Wemos
Subject:
Education, Science and Technology
Title:
Protection of clinical trial participants in countries outside the EU